Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Elevance Health Inc shares valued at $1,949,074 were sold by Kaye Mark on Apr 24 ’25. At $424.82 per share, Kaye Mark sold 4,588 shares. The insider’s holdings dropped to 18,977 shares worth approximately $7.3 million following the completion of this transaction.
Also, Kaye Mark purchased 4,588 shares, netting a total of over 1,949,051 in proceeds.
Before that, Penczek Ronald W had sold 443 shares from its account. In a trade valued at $183,903, the CAO & Controller traded Elevance Health Inc shares for $415.13 each. Upon closing the transaction, the insider’s holdings decreased to 443 shares, worth approximately $0.71 million.
As published in a research note from Robert W. Baird on April 15, 2025, Elevance Health Inc [ELV] has been rated down from an Outperform to a Neutral and the price target has been revised to $529. Analysts at Argus upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid March. As of January 22, 2025, Stephens has decreased its “an Overweight” rating to a “an Equal-weight” for ELV. Earlier on October 18, 2024, Argus downgraded its rating. Their new recommendation was “a Hold” for ELV stock which previously was a “a Buy”.
Analyzing ELV Stock Performance
During the last five days, there has been a drop of approximately -1.41%. Over the course of the year, Elevance Health Inc shares have jumped approximately 4.23%. Shares of the company reached a 52-week high of $458.75 on 04/08/25 and a 52-week low of $357.45 on 05/15/25.
Support And Resistance Levels for Elevance Health Inc (ELV)
According to the 24-hour chart, there is a support level at 378.82, which, if violated, would cause prices to drop to 373.12. In the upper region, resistance lies at 395.13. The next price resistance is at 405.74. RSI (Relative Strength Index) is 40.47 on the 14-day chart, showing neutral technical sentiment.
